| abstract |
Disclosed is a therapeutic agent for HTLV-1-associated diseases such as HTLV-1-associated myelopathy and uveitides. Specifically disclosed is a pharmaceutical agent comprising, as an active ingredient, an RAR agonist represented by formula (I) [wherein R1 to R5 independently represent a hydrogen atom, an alkyl group, or an alkyl-substituted silyl group; X represents -CO-NH-, -NH-CO- or -CO-CH=CH-; and A represents a carboxylate-substituted aromatic group or a tropolonyl group]. |